Visual compatibility of sargramostim with selected antineoplastic agents, anti-infectives, or other drugs during simulated Y-site injection.
Trissel
L A
LA
University of Texas M.D. Anderson Cancer Center, Houston.
Bready
B B
BB
Kwan
J W
JW
Santiago
N M
NM
D000890:Anti-Infective Agents / Q000737:chemistry*; D000970:Antineoplastic Agents / Q000737:chemistry*; D004344:Drug Incompatibility; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000737:chemistry*; D010289:Parenteral Nutrition, Total; D011994:Recombinant Proteins / Q000737:chemistry; D012996:Solutions
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D012996:Solutions; D016178:Granulocyte-Macrophage Colony-Stimulating Factor